Median Oxybenzone Levels in Blood More Than Doubled Over a Decade, Study Finds
The median level of oxybenzone in the blood of the same 216 retired workers in China more than doubled between 2008 and 2018. Oxybenzone is still used in Australian sunscreens, though Australia's medicines regulator found it "is not deemed to present a low risk to human health and safety".

Levels of oxybenzone in the blood of 216 retired workers in China rose significantly between 2008 and 2018, a new study has found (Zou et al., 2026). The Australian Sunscreen Council is calling for oxybenzone to be banned from Australian sunscreen, where it is still used (Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026, item 3645).
The same people were tested three times, about five years apart (Zou et al., 2026, p. B). The median level of oxybenzone in their blood more than doubled, from 0.025 ng/mL in 2008 to 0.055 ng/mL in 2018 (Zou et al., 2026, Supporting Information, Table S4). The researchers reported that oxybenzone "exhibited a significant rise in all participants (P for trend <0.001), especially in 2018" (Zou et al., 2026, p. D).
What the TGA found
This is a failure of Australia's medicines regulator, the Therapeutic Goods Administration (TGA). A September 2025 brief for its scheduling delegate recorded: "Animal studies showed reproductive, developmental, and endocrine effects, with some evidence of carcinogenicity and genotoxicity. Long-term human risk remains uncertain." (Therapeutic Goods Administration [TGA], 2025c, p. 4 of 9). Its own May 2025 safety review, released under FOI 26-2156, recommended "that oxybenzone is listed in the Poisons Standard" (TGA, 2025a, p. 61 of 74), and in July 2025 the TGA proposed "a new CAUTION (Schedule 5) entry for oxybenzone", with exemptions for some products (TGA, 2025b, p. 11). In March 2026 the TGA said its interim decision "will be published and subject to public consultation in early 2026" (TGA, 2026a, p. 17). None has been published. The TGA's Sunscreen ingredients page, last updated on 11 September 2026, now says: "The interim decision on these ingredients will be published and subject to public consultation by the end of 2026" (TGA, 2026b). The same brief recorded: "Oxybenzone is not currently scheduled and has not been previously considered for scheduling" (TGA, 2025c, p. 4 of 9). Today oxybenzone is still used in Australian sunscreens (Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026, item 3645), and it is still unscheduled.
The same brief said: "Oxybenzone is rapidly absorbed and detected in plasma and breast milk" (TGA, 2025c, p. 4 of 9).
What the study found
The study, by Zou and colleagues, was published in ACS ES&T Toxicology in October 2026. It measured five benzophenone UV filters in blood serum from retired workers in China, at three survey waves from 2008 to 2018 (Zou et al., 2026, pp. A–B). Oxybenzone is also called benzophenone-3 (BP-3). The researchers describe benzophenones as "the most widely used organic UV filters" (Zou et al., 2026, p. A).
Oxybenzone was the most frequently detected of the five benzophenone UV filters measured, and its concentration increased over time (Zou et al., 2026, p. A). Four other benzophenone chemicals also turned up in more people's blood over the decade (Zou et al., 2026, p. A).
The researchers said the rise "may partly reflect changes in the use of BP-containing products during the study period", and noted that "In China, the use of BP-3 in cosmetics and cosmetics consumption has grown rapidly over the past decade" (Zou et al., 2026, p. F). The rise was "broadly consistent with the increasing pattern reported in the U.S. general population" (Zou et al., 2026, p. F). The researchers wrote that "the increasing occurrence of multiple BP congeners also underscores the need to further evaluate their potential health implications" (Zou et al., 2026, p. F).
The researchers wrote: "Higher BP-3 concentrations were nominally associated with elevated LDL-C and non-HDL-C levels, but not TC or TG, although these associations did not remain statistically significant after multiple-testing correction" (Zou et al., 2026, p. F). LDL-C and non-HDL-C are cholesterol measures; TC is total cholesterol and TG is triglycerides. The researchers described "suggestive associations between BP-3 exposure and cholesterol-related lipid measures" and called for larger studies to confirm them (Zou et al., 2026, p. A).
What other regulators have done
The European Union restricts oxybenzone, listed in its rules as Benzophenone-3, as a UV filter in cosmetic products under Commission Regulation (EU) 2022/1176 (European Commission, 2022, p. 52, recital 8). The regulation records that a call for data was launched in 2019 "in light of concerns related to potential endocrine disrupting properties of Benzophenone-3 and Octocrylene, when used as UV filters in cosmetic products" (European Commission, 2022, p. 51, recital 2), and the European Commission concluded that "there is potential risk to human health arising from the use of Benzophenone-3 and Octocrylene as UV filters in cosmetic products in the concentrations currently allowed" (European Commission, 2022, p. 52, recital 8).
In Australia, the Therapeutic Goods Administration's own safety review, released under Freedom of Information, states: "Benzophenone, an important impurity and degradant of octocrylene, is considered to be genotoxic, carcinogenic and shown to disrupt endocrine signalling" (TGA, 2025a, p. 54 of 74).
The United States Food and Drug Administration (FDA) wrote in 2021: "Given the available data showing significant transdermal absorption and systemic availability of oxybenzone, as well as the potential for endocrine activity, we propose that sunscreens containing oxybenzone are not GRASE", GRASE meaning generally recognised as safe and effective (U.S. Food and Drug Administration [FDA], 2021, p. 44). Transdermal means through the skin.
Denmark's Environmental Protection Agency concluded that oxybenzone "is an endocrine disruptor for the human health and for the environment" (Danish Environmental Protection Agency, 2025, p. 9).
What the Australian Sunscreen Council is calling for
The Australian Sunscreen Council points to TGA FOI 26-2156, which revealed the regulator's own May 2025 safety review recorded that, in a rat study, "Exposure to oxybenzone was associated with" an increase in "nonneoplastic kidney lesions in the F0, F1, and F2 generations" at the highest dose (TGA, 2025a, p. 37 of 74), and that in rats, "Liver was the major distribution site of oxybenzone" (TGA, 2025a, p. 23 of 74). The Council is calling for oxybenzone to be banned in Australian sunscreen.
Non-nano zinc oxide is the only broad-spectrum UV filter that is reef safe and Generally Recognized As Safe and Effective (GRASE) by the US FDA (National Oceanic and Atmospheric Administration [NOAA], n.d.; National Park Service [NPS], n.d.; FDA, 2019, p. 6206; Beasley & Meyer, 2010; Hanrahan, 2012). On its own it protects across the full UVA and UVB range, including long UVA (Beasley & Meyer, 2010; Hanrahan, 2012).
The United States (FDA) now classifies bemotrizinol as generally recognized as safe and effective for over-the-counter sunscreens, under conditions set in its June 2026 final order (FDA, 2026, p. 8). The final order says "FDA concludes that bemotrizinol is GRASE for use as an active ingredient in OTC sunscreen drug products under the conditions set forth in Section IX of this document, and other applicable requirements." (FDA, 2026, p. 8). In its December 2025 proposed order, the FDA described bemotrizinol as exhibiting "high photostability and broad-spectrum coverage across the UVB (280 to 320 nanometers (nm)) and UVA (320 to 400 nm) ranges" (FDA, 2025, p. 5).
Other sun protection
Sunscreen is one part of sun protection. Cancer Council Australia says "Sunscreen is not a suit of armour and should be used with the other four sun protection measures" (Cancer Council Australia, n.d.). Its advice is to wear sun-protective clothing: "Choose clothing that covers as much skin as possible (think shirts with long sleeves)." Some clothing "may carry an ultraviolet protection factor (UPF), which is a guarantee of how much UV protection a fabric provides" (Cancer Council Australia, n.d.). Add a "broad-brimmed hat", "Seek shade" and wear "close-fitting wraparound sunglasses, that meet Australian Standards" (Cancer Council Australia, n.d.). The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) says "There is more to sun protection than just sunscreen. No sunscreen provides complete protection against UVR" (ARPANSA, n.d.).
About the Australian Sunscreen Council
The Australian Sunscreen Council is a registered Australian charity dedicated to improving the health of everyday Australians through UV education, research and evidence-based sun safety initiatives.
As Australia’s peak industry body for sunscreen safety, the Council works with scientists, medical professionals, industry experts and policymakers to advance sunscreen safety, support independent research, improve public understanding of UV exposure and promote stronger public-health standards.
ABN 64 692 134 982
Australian Sunscreen Council Editorial Team
The Council is supported by an Expert Group and may draw on advice from one or more members depending on the subject matter of a particular article, submission or publication. Members listed by the Council include (Australian Sunscreen Council, n.d.):
Dr Craig Downs, Executive Director, Haereticus Environmental Laboratory
Dr Russell Hills, cosmetic and laser dermatologist and Mohs specialist
Dr Denis Dudley, obstetrician-gynaecologist and endocrinologist
Dr Abhinandan “Rocky” Chowdhury, toxicologist
Dr Leslie Laquieze, sunscreen testing and photoprotection
Mgr. Mehrdad Mirzaei, pharmacist and photoprotection researcher
Joseph DiNardo, cosmetic toxicologist
Dr Alan Jones, skin cancer physician
Camila Biato Stopa, MSc, cosmetic scientist and pharmacist
Acknowledgment
Grok was used in the creation of this article. Always read the sunscreen label and use only as directed. Sunscreen is only one part of sun protection. Avoid prolonged sun exposure and wear protective clothing, hats, and eyewear.
References
Australian Radiation Protection and Nuclear Safety Agency. (n.d.). Sun protection using sunscreens. Retrieved November 1, 2026, from https://www.arpansa.gov.au/understanding-radiation/radiation-sources/more-radiation-sources/sun-protection-sunscreen
Australian Sunscreen Council. (n.d.). Scientific experts in sunscreen safety. Retrieved October 24, 2026, from https://www.australiansunscreencouncil.org/scientific-experts-sunscreen-safety
Beasley, D. G., & Meyer, T. A. (2010). Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. American Journal of Clinical Dermatology, 11(6), 413–421. https://doi.org/10.2165/11537050-000000000-00000
Cancer Council Australia. (n.d.). Protect your skin in five simple steps. Retrieved November 1, 2026, from https://www.cancer.org.au/save-your-skin/five-sunsmart-steps
Danish Environmental Protection Agency. (2025, August 6). Substance evaluation conclusion and evaluation report for oxybenzone (BP-3), EC 205-031-5 [Denmark, evaluating Member State Competent Authority, REACH substance evaluation]. European Chemicals Agency. https://chem.echa.europa.eu/api-activity-list/v1/substanceEvaluation/documents?name=3d9250c025a0c88b1b70d3fcdef2c4b1_SEV-205-031-5-1_Conclusion_public.pdf
European Commission. (2022). Commission Regulation (EU) 2022/1176 of 7 July 2022 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of certain UV filters in cosmetic products. Official Journal of the European Union, L 183, 51–53. https://eur-lex.europa.eu/eli/reg/2022/1176/oj
Hanrahan, J. R. (2012). Sunscreens. Australian Prescriber, 35(5), 148–151. https://doi.org/10.18773/austprescr.2012.068
National Oceanic and Atmospheric Administration. (n.d.). Skincare chemicals and marine life. National Ocean Service. Retrieved October 10, 2026, from https://oceanservice.noaa.gov/news/sunscreen-corals.html
National Park Service. (n.d.). Sunscreen. U.S. Department of the Interior. Retrieved October 10, 2026, from https://www.nps.gov/subjects/oceans/sunscreen.htm
Therapeutic Goods Administration. (2025a, May). Safety review of seven active sunscreen ingredients (Version 1.0) [Released under FOI 26-2156, Document 4]. https://www.tga.gov.au/sites/default/files/2026-06/FOI%2026-2156.PDF
Therapeutic Goods Administration. (2025b, July 8). Consultation: Proposed amendments to the Poisons Standard in relation to homosalate, oxybenzone and benzophenone – Joint ACMS-ACCS #41 meeting, September 2025. https://consultations.tga.gov.au/tga/scheduling-pre-meeting-sunscreen-substances-sep-25/user_uploads/pre-meeting-public-notice---joint-41---homosalate-oxybenzone-benzophenone---sep-2025-1.pdf
Therapeutic Goods Administration. (2025c, September 17). Pre-meeting brief on agenda papers: Joint Advisory Committee on Chemicals and Medicines Scheduling (Joint ACMS-ACCS) #41 [Released under FOI 26-3100, Document 1]. https://www.tga.gov.au/sites/default/files/2026-07/FOI%2026-3100.pdf
Therapeutic Goods Administration. (2026a, March). Consultation: Seeking feedback on improvements to the regulation of sunscreens in Australia (Version 1.0). https://consultations.tga.gov.au/tga/improvements-to-regulation-of-sunscreens-in-aus/
Therapeutic Goods Administration. (2026b, September 11). Sunscreen ingredients [Web page]. Retrieved October 24, 2026, from https://www.tga.gov.au/resources/explore-topic/sunscreens/sunscreen-ingredients
Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (Cth). F2026L01382. https://www.legislation.gov.au/F2026L01382/latest/text
U.S. Food and Drug Administration. (2019, February 26). Sunscreen drug products for over-the-counter human use (Proposed rule, 84 Fed. Reg. 6204; Docket No. FDA-1978-N-0018). Federal Register. https://www.govinfo.gov/content/pkg/FR-2019-02-26/pdf/2019-03019.pdf
U.S. Food and Drug Administration. (2021, September 24). Proposed order (OTC000008): Amending over-the-counter (OTC) monograph M020: Sunscreen drug products for OTC human use. OTC Monographs@FDA. https://www.accessdata.fda.gov/scripts/cder/omuf/index.cfm
U.S. Food and Drug Administration. (2025, December 12). Proposed administrative order (OTC000039): Amending over-the-counter monograph M020: Sunscreen drug products for over-the-counter human use (Docket No. FDA-2025-N-6494; 90 Fed. Reg. 57765). https://www.accessdata.fda.gov/drugsatfda_docs/omuf/Order/supportDoc/OTC000039/Internal_Documents/2025.12.09%20ProposedOrder_BemotrizinolOTC000039_090026f88e15dab6.pdf
U.S. Food and Drug Administration. (2026, June 10). Final administrative order (OTC000039): Amending over-the-counter monograph M020: Sunscreen drug products for over-the-counter human use, and related information [Corrected version, August 10, 2026] (Docket No. FDA-2025-N-6494; 91 Fed. Reg. 35220). https://www.accessdata.fda.gov/drugsatfda_docs/omuf/Order/OTC000039_Final_Administrative_Order.pdf
Zou, J., Zhang, J., Gao, C., Guo, H., Liu, L., Ma, J., Xiao, Z., Li, Z., Luo, Y., Cheng, X., & He, M. (2026). Temporal trends in serum benzophenone-type ultraviolet filters and longitudinal associations of BP-3 with lipids from 2008 to 2018: The Dongfeng-Tongji Cohort Study. ACS ES&T Toxicology. Advance online publication. https://doi.org/10.1021/acsesttox.6c00063




